Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8924986 | Journal of Stomatology, Oral and Maxillofacial Surgery | 2017 | 9 Pages |
Abstract
Our study shows that the postoperative healing rate of ONJ lies between 57Â and 66.7Â % at 6Â months and that this rate was optimized in the order of 10Â % to 12Â months and stable at 18Â months postoperatively. The ONJ of our series were partially or fully linked to other drugs than bisphosphonates in 70Â % of the cases: 50Â % were related to denosumab, alone or in combination and 35Â % were related to an association with antiangiogenics, bevacizumab mainly.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
A. Berquet, A. Louvrier, F. Denis, F. Bornert, E. Weber, C. Meyer,